|Last Price$25.20||Day Change (%)0.20%|
|Open Price$25.20||Day Change ($)0.05|
|Day Range25.20–25.20||52-Week Range20.03–25.36|
As of Fri 06/23/2017 | USD
QuintilesIMS to Participate in William Blair Growth Stock Conference on June 14, 2017
Dr. Reddy's Laboratories Announces the Launch of Bivalirudin for Injection in the U.S. Market
QuintilesIMS Announces Launch of Secondary Public Offering, Repurchase of Common Stock and Increase in Share Buyback Authorization
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.